The Celiac Disease Foundation is proud to share that for the second year in a row, access to funding for celiac disease research is being made available through the U.S. DOD Congressionally Directed Medical Research Programs (DOD-CDMRP)Peer Review Medical Research Program ..read more

The Celiac Disease Foundation has joined forces with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Foundation to introduce two groundbreaking awards specifically designed to advance celiac disease research. These initiatives aim to foster novel research endeavors, emphasizing the importance for medical professionals to delve into the complexities of this lifelong autoimmune condition.  ..read more

Earlier this month, SSCD hosted their first quarterly webinar of 2024 on “Under-Represented Populations in Celiac Disease.” During the webinar, the Celiac Disease Foundation and SSCD announced the launch of the Improving Health Equity in Celiac Disease Through Disparities Research Award ..read more

A new study published in the journal Gastro Hep Advances finds that a considerable proportion of Black patients with biopsy-confirmed celiac disease had negative diagnostic blood tests. Traditionally perceived as predominantly affecting non-Hispanic White individuals, this study underscores the importance of bridging existing research gaps to better serve underrepresented populations.  ..read more

Using data from the Foundation’s iCureCeliac® Patient Registry, a new observational study helps explain the relationship between persistent celiac disease symptoms, gluten-free diet adherence, mental health, and quality of life ..read more

The Celiac Disease Foundation is proud to announce that Robert Anderson, MB, ChB, PhD, has joined the Foundation as its Principal Science & Innovation Advisor. In his new role, Dr. Anderson will draw on his extensive background to provide scientific expertise and guidance to the organization and its stakeholders.   ..read more

Otorhinolaryngological (ORL) – better known as ear, nose, and throat – complaints in celiac disease are considered rare and are often overlooked by physicians. A recent international narrative review analyzed the latest evidence on the association among celiac disease, ORL, and esophageal symptoms.  ..read more

Chugai Pharmaceutical Co., Ltd. recently published encouraging results from a non-clinical study on DONQ52, an experimental medication for celiac disease. The findings show its potential to block the immune response to gluten in celiac disease without affecting the rest of the immune system.   ..read more

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease ..read more

A recent study published in The Lancet Journal of Gastroenterology & Hepatology sought to determine the accuracy of blood (serological) tests in celiac disease diagnosis in adults. The results of this study are interesting, to say the least ..read more